Non Small Cell Lung Cancer Clinical Trials 2022

NSCLC studies recruiting patients for novel treatments. Filter by phase, distance, and inclusion criteria to find your perfect non small cell lung cancer clinical trial in 2022.

Phase-Based Estimates
1
Effectiveness
1
Safety

Pembrolizumabfor Mesothelioma

Phase 1 & 2
Recruiting
Bethesda, MD
18+
All Sexes
Phase-Based Estimates
1
Effectiveness
1
Safety

Durvalumab (MEDI 4736)for Carcinoma, Non-Small-Cell Lung

Phase 1 & 2
Waitlist Available
Los Angeles, CA
18+
All Sexes